Elevated CCL2 has been detected in the cerebrospinal fluid (CSF) of patients with Alzheimer’s disease (AD) and HIV-associated neurocognitive disorder (HAND) [6–9]. Here, CCL2 is linked to early-onset autosomal dominant Alzheimer disease.